“Pharmaceutical companies who wish to sell their products globally need to meet the safety related governance and regulatory standards that each region and country mandates and this has meant that companies were forced meet their global safety requirements using separate applications and databases and exchanging cases through error-prone and inefficient processes. The ARISg / ARISj solution eliminates the duplication and manual manipulation of this important information for global companies.“ said Deepak Abbhi, President & CEO of ArisGlobal.
Without ARISg / ARISj, a pharmaceutical company would need to use multiple separate systems, with multiple databases, multiple validated environments, multiple configurations and workflows, and then would need to duplicate or double-enter cases, which is risky and inefficient.
With ARISg / ARISj, the pharmaceutical company can implement the most cost effective, proven and complete solution available today.
ArisGlobal is the only provider that has customers who have implemented and validated a worldwide solution creating for them a single, global safety information system that meets the needs of Europe, the United States and Japan. No other vendor in the world can say this or even offers a regulatory compliant global solution.
About ArisGlobal
ArisGlobal (www.arisglobal.com) is a leading provider of integrated software solutions for pharmacovigilance and safety, regulatory affairs, clinical research and medical information. Hundreds of life science companies rely on ArisGlobal’s advanced solutions for maintaining regulatory compliance, workflow automation, improving operational efficiency and easily sharing information around the globe.
Contact
Kathy Capper
ArisGlobal
+ 44 (0)1908 506075
kcapper@arisglobal.com
